The Food Label and You: Game Show Review (Are You Smarter Than A Food Label?) (Historical PSA)

Spoof of the popular game show, this segment pits FDA's "Labelman" against a contestant in food label knowledge. Questions cover topics such as Calories, Serving Size, Servings per Container, The 5-20 Rule and more. Produced by CDRH-TV for CFSAN [vpfood] NOTE: FDA has issued final changes to update the Nutrition Facts label for packaged foods. For more information, read the Changes to the Nutrition Facts Label webpage: https://www.fda.gov/food/food-labelin...

The Food Label and You (Historical PSA)
▶︎

The Food Label and You (Historical PSA)

The Food Label and You: Party Food (Gametime/Play By Play) (Historical PSA)
▶︎

The Food Label and You: Party Food (Gametime/Play By Play) (Historical PSA)

MEDIA CALL: Front of Package Nutrition Labels – 1/14/2025
▶︎

MEDIA CALL: Front of Package Nutrition Labels – 1/14/2025

AGDD 2025 | D2S03 - Common Deficiencies and Resolutions: Complex Drug Substance/Excipients/Products
▶︎

AGDD 2025 | D2S03 - Common Deficiencies and Resolutions: Complex Drug Substance/Excipients/Products

Fresh and Frozen Seafood: Selecting and Serving it Safely
▶︎

Fresh and Frozen Seafood: Selecting and Serving it Safely

The Food Label and You: Road Food (Finding Nutrition Information on the Road) (Historical PSA)
▶︎

The Food Label and You: Road Food (Finding Nutrition Information on the Road) (Historical PSA)

The Food Label and You: The 5-20 Rule Part 2 (Historical PSA)
▶︎

The Food Label and You: The 5-20 Rule Part 2 (Historical PSA)

AGDD 2025 | D1S02 - Novel Bioequivalence Study Design Recommendations
▶︎

AGDD 2025 | D1S02 - Novel Bioequivalence Study Design Recommendations

Considerations for Collecting/Using Natural History Data Fit for Use in the Regulatory Setting
▶︎

Considerations for Collecting/Using Natural History Data Fit for Use in the Regulatory Setting

AGDD 2025 | D2S04 - Nitrosamines: Known Issues and Practical Advice
▶︎

AGDD 2025 | D2S04 - Nitrosamines: Known Issues and Practical Advice

AGDD 2025 | D1S01 - Product-Specific Guidance for Complex Products: From Research to Standards
▶︎

AGDD 2025 | D1S01 - Product-Specific Guidance for Complex Products: From Research to Standards

AGDD 2025 | D2S05 - Workshop Closing Remarks
▶︎

AGDD 2025 | D2S05 - Workshop Closing Remarks

AGDD 2025 | D1S03 - Day One Closing Remarks
▶︎

AGDD 2025 | D1S03 - Day One Closing Remarks

FDA Webinar: Safety Assessment of Genome Editing in Gene Therapy
▶︎

FDA Webinar: Safety Assessment of Genome Editing in Gene Therapy

FDA Grand Rounds: FDA Menopausal Hormone Therapy (MHT) Labeling: Historical Context & Recent Changes
▶︎

FDA Grand Rounds: FDA Menopausal Hormone Therapy (MHT) Labeling: Historical Context & Recent Changes

AGDD 2025 | D1S00 - Welcome and Opening Remarks
▶︎

AGDD 2025 | D1S00 - Welcome and Opening Remarks

Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers
▶︎

Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers

193rd Vaccines and Related Biological Products Advisory Committee Meeting
▶︎

193rd Vaccines and Related Biological Products Advisory Committee Meeting

Understanding Endpoints in Rare Disease Drug Development
▶︎

Understanding Endpoints in Rare Disease Drug Development

Office of New Drugs Standard Safety Tables and Figures for New Drug and Biologic Applications
▶︎

Office of New Drugs Standard Safety Tables and Figures for New Drug and Biologic Applications